Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 6, 2005
[Mutation of mitochondrial 12S rRNA in gastric carcinomas and its significance]Cheng-bo Han, Yan Xin, Xue-fei Yang, et al.
World Journal of Gastroenterology|June 2, 2005
Relationship between abnormality of FHIT gene and EBV infection in gastric cancerYu-Ping Xiao, Cheng-Bo Han, Xiao-Yun Mao, et al.
Oncology Letters|September 13, 2012
Synergistic cytotoxic effects of recombinant human adenovirus p53 and radiation at various time points in A549 lung adenocarcinoma cellsJie-Tao Ma, Cheng-Bo Han, Jian-Zhu Zhao, et al.
World Journal of Gastroenterology|September 13, 2003
Variations of mitochondrial D-loop region plus downstream gene 1 2S rRNA-tRNA(phe) and gastric carcinomasCheng-Bo Han, Fan Li, Yu-Jie Zhao, et al.
Nuclear Medicine Communications|May 11, 2017
Hybrid PET/MRI-based delineation of gross tumor volume in head and neck cancer and tumor parameter analysisJie-Tao Ma, Cheng-Bo Han, Jia-He Zheng, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 2014
Pulmonary artery invasion, high-dose radiation, and overall survival in patients with non-small cell lung cancerCheng-Bo Han, Wei-Li Wang, Leslie Quint, et al.
Radiation Oncology (London, England)|February 2, 2017
Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?Jie-Tao Ma, Li Sun, Xin Sun, et al.
Cancer Medicine|October 3, 2024
The Optimal First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer Based on Liver Metastasis Status: A Network Meta-Analysis and Systematic ReviewShu-Ling Zhang, Jing Yu, Yuan Tian, et al.
Nuclear Medicine Communications|December 11, 2013
Detection of residual tumor following radiofrequency ablation of liver metastases using 18F-FDG PET/PET-CT: a systematic review and meta-analysisJia-He Zheng, Zhi-Hui Chang, Cheng-Bo Han, et al.
Lung Cancer (Amsterdam, Netherlands)|April 26, 2024
Is neoadjuvant immunotherapy necessary in patients with programmed death ligand 1 expression-negative resectable non-small cell lung cancer? A systematic review and meta-analysisShu-Ling Zhang, Yuan Tian, Jing Yu, et al.
Pageof 5